DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Namenda (Memantine) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Namenda (Memantine) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Namenda side effects in 78 year old male

Reported by a individual with unspecified qualification from United States on 2012-02-02

Patient: 78 year old male, weighing 36.3 kg (79.8 pounds)

Reactions: Affective Disorder, Balance Disorder, Aphasia, Amnesia, Loss of Consciousness, Convulsion

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Namenda



Possible Namenda side effects in 82 year old male

Reported by a physician from United States on 2011-12-01

Patient: 82 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Blood Bilirubin Increased, Blood Alkaline Phosphatase Increased, Refusal of Treatment by Patient, Alanine Aminotransferase Increased, Blood Bilirubin Unconjugated Increased, Pyrexia, Cholecystitis Chronic, Lactic Acidosis, Fall, Cholelithiasis, Aspartate Aminotransferase Increased, Dizziness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Aricept
    Administration route: Oral
    Indication: Dementia Alzheimer's Type
    Start date: 2009-12-15

Placebo
    Indication: Dementia Alzheimer's Type
    Start date: 2011-08-05

Namenda
    Administration route: Oral
    Indication: Dementia Alzheimer's Type
    Start date: 2010-01-08

Other drugs received by patient: Aspirin; Ascorbic Acid; Multi-Vitamins; Cephalexin; Iron



Possible Namenda side effects in female

Reported by a physician from United States on 2011-11-04

Patient: female, weighing 56.7 kg (124.7 pounds)

Reactions: Chest Discomfort, Bundle Branch Block Left, Concomitant Disease Progression, Loss of Consciousness, Chest Pain, Dizziness, Acute Myocardial Infarction, Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Namenda
    Dosage: 10 mg, bid
    Administration route: Oral
    Indication: Dementia Alzheimer's Type
    Start date: 2007-02-13
    End date: 2007-05-13

Exelon
    Dosage: 3 mg, bid
    Administration route: Oral
    Indication: Dementia Alzheimer's Type
    Start date: 2007-02-13
    End date: 2007-05-13

Other drugs received by patient: Warfarin Sodium; Toprol-XL; Lisinopril

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017